Citation: Pandey P, Acharya M. Disease-phenotype deconvolution in genetic eye diseases using online Mendelian inheritance in man. Invest Ophthalmol Vis Sci. 2016;57:289557: -290457: . DOI:10.1167 PURPOSE. Capturing organ-specific phenomes in genetic diseases is an uphill task for the eye as it comprises tissue types derived from all three germinal layers. We attempted to deconstruct genetic eye diseases (GEDs) into primary phenotypic features, to understand the complex genome-phenome relationship in GEDs.
C linical signs and symptoms are the process of defining a disease and a large number of abnormal phenotypic features are considered in connection with a single or small subset of disease. This method is convenient for practicing clinicians, although it obliterates ample phenotypic prominence that could be catalogued by insightful and unbiased clinical investigation. With the progress in human genomics research, one of the primary obstacles in clinical research that emerges is the lack of systematic investigation on the interconnectivity of the disease genotype and clinical phenotype. Despite massive improvements of the genomic technologies during past few years, it is still an uphill task to capture the set of all disease-related phenotypes expressed in a specific organ (i.e., the disease phenome). One such attempt has been taken for genetic skin diseases where deconvolving human disease into distinctive features created a third module that interacts with both disease and genotype. 1 Briefly, using cutaneous and noncutaneous clinical findings associated with genetic skin diseases from the Online Mendelian Inheritance in Man (OMIM) database, the authors provided a framework for analyzing medical disorders which can aid in the organization and elucidation of biological mechanisms related to human disease. 1 Scharfe et al. 2 showed a similar approach on human mitochondria and clinical disease phenotypes. In this study, we intend to investigate the concordance of this approach to other genetic diseases. Here we take genetic eye diseases to understand complex relationship between genome and phenome in ocular diseases using a disease deconvolution approach. Since the eye is a unique sensory organ comprising of tissue types from all three germinal layers, it would be an excellent structure to study gene-disease-phenotype interconnectivity. We considered gene, disease, and phenotype as three separate entities that can interact with each other. Considering the disease-phenotype interactions, cluster analysis was done on a specific phenotype unit to give rise to disease clusters. This concept can further be expanded as OMIM contains mostly inherited human diseases, where each disease is connected to a gene. This enables us to create a biological network of genes from the clusters and identify biological processes and pathways associated with a specific disease cluster. A brief outline of our study design is depicted in Figure  1A .
An argument could be made over choosing OMIM to study disease deconvolution especially in the context of complex human diseases, as OMIM mostly focuses on inherited human diseases and the majority of these are single gene disorders. Conversely, OMIM is the most comprehensive genetic disease database to date. We understand eye diseases enlisted in OMIM would mostly be single-gene diseases with multiple shared phenotypes among them. In this study, we aimed to conduct a comprehensive investigation of phenotype overlaps in Mendelian eye diseases for both ocular and systemic features, which in turn would enable us to identify common biological processes in relatively unrelated ocular and nonocular diseases. The natural tendency of focusing on organspecific disease management usually ignores signals in terms iovs.arvojournals.org j ISSN: 1552-5783 of phenotypes at other apparently unrelated nonassertive sites in the human body. For instance, a number of nonretinal diseases are associated with diabetes 3 and systemic inflammation due to immunoactivation is functionally linked to agerelated macular degeneration. 4 The phenomic architecture can therefore facilitate in understanding molecular mechanisms related to genetic eye diseases. Therefore, the rationale is: to identify and capture the entire disease phenome for genetic eye diseases, to better understand gene-diseasephenotype interconnectivity, identify global and local disease clusters with shared common ocular phenotypes, determine pathway identification from disease clusters, and identify systemic phenotypes and associated disorders for specific ocular disease.
METHODS Data Retrieval Using OMIM
We began our search in OMIM using ''eye'' as a keyword, which resulted in 1308 entries (as of November 2013) under six OMIM categories: known phenotype description and molecular basis; known gene descriptions; known gene and phenotypes; known phenotype description or locus, molecular basis; other, mainly phenotypes with suspected Mendelian basis; and microRNA (Figs. 1B, 1C ). We considered three major categories of OMIM for further filtering: phenotype description, molecular basis known (PMK); phenotype description or locus, molecular basis unknown (PMU); and gene description (GD). We used several built-in OMIM filters to obtain a minimum number of PMU entries and a maximum number of entries matched between PMK and GD to minimize entries with unknown molecular bases or loci. Finally, we filtered 527 disease entries that had an equal number of PMK and GD to configure our primary dataset for entire analyses in this study (Figs. 1B, 1C ).
Phenotype Curation and Deconvolution
Each OMIM entry referred to an individual disease. We checked diseases that are reported to be caused by more than one gene mutation (i.e., polygenic diseases and single genes causing multiple diseases). We extracted elemental features, both ocular and systemic from each disease (e.g., ocular findings, neurological findings, cardiovascular findings) to deconstruct the features.
Using the file transfer protocol site of OMIM, ''omim.txt,'' ''mim2gene.txt,'' ''morbidmap.txt,'' ''genemap2.txt,'' and ''genemap.key'' were downloaded. Custom written Perl scripts were used to format and extract information from these files to create our own repository, described in Supplementary Table  S1 . Information such as ocular phenotype description, mode of inheritance, gene symbols, gene ID, disease name, MIM ID, and description on systemic phenotypes on field ''eye'' was extracted from the above mentioned tables. Total number of genes causing 527 ocular diseases was obtained (Supplementary Table S1 ). We defined ocular and systemic phenotype groups based on similar features shared among the individual phenotype. The relationship between individual phenotype and number of disorders sharing it was computed. For example, number of disorders caused by each gene and the ocular and systemic phenotypes shared by these diseases per gene was computed. Poorly described MIM IDs for which no phenotype description was available were not considered for further analysis.
Databases such as DisGeNET 5 and Human Phenotype Ontology (HPO 6 ) were explored to obtain more information. Most of these databases contain phenotype annotations on human monogenic disorders including eye diseases. They are mainly consisting of clinical features for each disease and a collection of features based on each phenotype-ocular as well as systemic is specific to our study. Moreover, these databases are mainly based on OMIM, which is the primary information database used in our study as well; therefore, no additional information from these publicly available databases are included at this time in our analysis.
Each ocular disease was checked for availability of ocular and systemic phenotypes and number of genes causing these diseases was further calculated. Based on this, disorders that contained both ocular and systemic phenotypic descriptions were separated first along with their causal genes. Next, diseases with their causal genes that have only either ocular or systemic phenotypes were computed. Per disease unit, average number of ocular and systemic features was also calculated.
For each ocular phenotype, the number of diseases sharing it was obtained. Per disease, the number of ocular and systemic phenotypes was collected. Distribution of ocular features among ocular disease units was obtained. Similarly, distributions of ocular features and disease units sharing them for each ocular group were identified. Furthermore, the most common ocular feature represented among the ocular disease units was identified. Individual ocular features were ranked based on the number of ocular disease units shared. Systemic features were grouped into broader classes and ranked. Of the 527 ocular disease units, the number of syndromes was identified.
Phenotype-Based Cluster Analysis
For functional clustering based on shared phenotypes, we assigned a ''1'' or ''0'' for the presence or absence of the specific phenotype (features derived from OMIM), respectively, for 787 independent ocular phenotypes. Thus each of these phenotypes is representing a unique dimension in the multidimensional space. Next, the Raup-Crick index method in PAST data analysis package (University of Oslo, Norway; available in the public domain at http://folk.uio.no/ohammer/ past) was used to perform hierarchical clustering of this binary data. From the main matrix, the 10 most represented phenotypic units were filtered and similar cluster dendrogram was created for them. For both unfiltered matrix and top 10 phenotypic units, the clusters above 80% similarity index were selected for further analyses.
Network Analysis
The genes present in the largest cluster above 80% similarity index for top 10 phenoytypic units and the unfiltered ''all ocular phenotypes'' were further considered for network analyses using GeneMANIA 7 module in the Cytoscape. 8 For all the analyses, Gene Ontology-Biological Processes was set as the default. Also, the default preset in GeneMANIA was used, which essentially allows 20 related genes of the query genes that are coming from the largest cluster for each phenotypic unit to form a network.
RESULTS
Genetic eye diseases (GEDs) from OMIM were deconvolved into ocular and systemic features as shown in Figures 1B, 1C , and Supplementary Table S1 . We excluded 7 out of 527 diseases that were polygenic from our study. The remaining 520 diseases were taken for our analyses and designated as GEDs. A total of 440 genes were found to be linked with these 520 GEDs. Out of these, 383 entries were found for one gene causing one disease. Similarly, 39, 15, and 2 entries were observed for one gene causing 2, 3, and 4 diseases, respectively. A single gene called paired box protein-6 (PAX6) was detected to be linked with a maximum number of six distinct but related GEDs (Figs. 2A, 2B). The mode of inheritance of GEDs is found to be variable, with a majority of them being autosomal (~75%). Autosomal recessive (43.69%) is the most represented mode of inheritance followed by autosomal dominant (32.02%). Inheritance that was x-linked was found in~9% GEDs, of which 3.2% are dominant and 3.58% are recessive. Only a minority are sporadic (1.88%), multifactorial (0.38%), somatic (0.38%), or mitochondrial (0.38%). Mode of inheritance is unknown in almost 12% of GEDs (Fig. 2C) .
Of the 520 disease units, there were a total of 787 ocular features for 363 disease units and 3094 systemic features for 380 disease units ( Fig. 3A ; Supplementary Table S2) , with an average of 2.17 ocular and 8.14 systemic features, respectively, Table S1 ). We randomly checked those diseases for possible ocular connections in the OMIM description and found isolated and nonreplicative case reports suggesting the presence of one or more eye-related pathophenotypes associated with them. The distributions of ocular and systemic features per disease unit are outlined in Figure 3B . Furthermore, we categorized GEDs based on their ocular and systemic features into broad groups. The ocular phenotype groups are mostly based on anatomically defined ocular compartments. Some exceptions such as developmental/ congenital condition, axial length, or malignancy are present, which actually define disease condition rather than ocular structures. Similarly, the systemic phenotype groups comprises mostly of organ systems. Altogether, 20 and 21 groups have been created to accommodate all ocular and systemic features, respectively (Table 1; Supplementary Table S4) . Prevalence of ocular and systemic features per ocular phenotypic group and systemic phenotypic group is depicted in Figures 4A and 4B (see also Table 1, Supplementary Table S4 ). Figure 4A shows a ranking of systemic features associated with the 380 GEDs. In aggregate, neurological phenotypes represent the most common class of systemic features. This is mostly because a major portion of the eye is originated from neural tube and neural crest layers. Consistent with this finding, retina tops the list of ocular disease groups with number of diseases and phenotypes. Also interestingly, the trend in the number of diseases and phenotypes for each group is almost opposite for systemic and ocular groups. A little more than half (52%) of the systemic groups have a greater number of phenotypes than diseases (''neurologic'' to ''immunology'' in Fig. 4A ) while 70% of the ocular groups have a greater more number of diseases than phenotypes (''extraocular muscle'' to ''malignant'' in Fig. 4B ).
We next focused on the ocular features associated with the GEDs. Distribution based on the number of ocular phenotypes present in GEDs was examined and most disease units (~44%) were found to have only one or two ocular phenotypes. The remaining diseases were found to have multiple distinct ocular features (Fig. 5A ). For instance, retinal cone dystrophy (OMIM 610356) has features of photophobia, myopia, astigmatism, strabismus, nystagmus, nyctalopia, macular atrophy, macular dysfunction, central scotoma on photopic and dark-adapted perimetry testing, and peripheral sensitivity loss. Although all these findings may be explained as direct or indirect consequences of gene KCNV2 mutations, we separately annotated these features to delineate the phenotypic relationship between retinal cone dystrophy and other conditions with nystagmus or macular dysfunction (Supplementary Table S1 ).
To uncover the hidden phenotypic structure within the disease space, we carried out an analysis that aimed at identifying subgroups of diseases sharing similar phenotypic Phenotype (Fig. 1A) . The analysis is performed to focus on the most common ocular phenotypes in GEDs (Fig.  5B , Supplementary Table S5 ). Nystagmus (EOM35), associated with 64 GEDs, is the most prevalent phenotype followed by hypertelorism (DV29), myopia (AL11), strabismus (EOM64), and microphthalmia (DV12; Table 2, Supplementary Table S5) . A number of systemic phenotypes were found to be associated with GEDs featuring the 10 ocular phenotypes. For example, the 64 disease units that are found to have EOM35 as a phenotype also contain a total of 643 unique systemic phenotype units where the neurologic systemic phenotype group (289) is predominant ( Table 2 ). In fact, among all systemic phenotype groups, neurologic (NEU) is the most prevalent one in the top 10 ocular phenotype units, followed by skeletal (SKL), craniofacial (HNC), and gastrointestinal (GIA). A detailed distribution of systemic phenotype groups across the top 10 ocular phenotypes is outlined in Figure 5C . To identify genetic interactions in ocular diseases sharing common ocular phenotypes, the top 10 ocular findings as depicted in Table 2 were further used for cluster analysis (Fig.  6) . A 1 or 0 was assigned for the presence or absence of the specific ocular features for a particular GED unit (Supplementary Table S6 ). Thus in the final analysis, the subspace defined by a particular ocular phenotype was represented as a matrix of 1's and 0's for number of GED units of 787 ocular phenotypes found (Supplementary Table S7 ). Figure 6 showed the similarity indexes based on feature clustering using Raup-Crick metrics for the presence or absence of data (http://folk.uio.no/ohammer/past).
To identify meaningful biological processes and pathways among GED loci sharing common phenotypes, genes associated with the largest disease cluster from each dendrogram of the 10 phenotypic units were subjected to network analysis using GeneMANIA (Supplementary Table S8 ). More than 90% of the genes derived from individual disease clusters of each phenotypic unit form a network (Fig. 7) . In all clustered gene-set analyses, physical interaction was on top followed by coexpression among the percent weight parameters of the edges of all networks. For all networks, we considered two attributes in GeneMANIA viz.: biological processes (based on Gene Ontology: GO) and consolidated pathways-2013. The analysis is summarized in Table  3 . For all gene networks, the top biological process matched with the top consolidated pathways-2013, suggesting consistency in functional nature of the network. For example, the importance of extracellular matrix structure and function is well known in glaucoma 9,10 ; our study, which designated these elements as ONH3, showed similar results (Table 3) . In most cases, a group of similar functions emerge as major attributes involving a few genes present within a cluster. For instance, four out of eight query genes (COL2A1, COL11A1, PLOD1, and NF1) in ONH3-cluster 4 are included in the extracellular structure organization ( Fig. 7 ; Table 3 ). However, for EL8-cluster 3, genes present within the 
DISCUSSION
In this study, we report on a general method for systematizing and deploying phenotypes using GED as a specific proof of principle. There are several notable observations. More than 
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73.6% of GEDs are caused by single gene defects, and 68.8% of the GEDs possess at least one ocular feature defined in OMIM.
There are one-gene-to-one-disease and one-gene-to-many disease association observed for these ocular diseases. The larger the pleiotropic effects in genetic disorders, the greater the genomic efforts to resolve the complexity. Hierarchical clustering on phenotypes could reveal the underlying structures of the disease based on its features. Hence, clinical findings could be digitized into discrete elements within the feature space much the same way a transcriptome can be digitized by a transcript. Our analysis of identifying subgroups of diseases uncovered several hidden groupings, including those related to central nervous system diseases such as neuropathy and developmental/congenital condition. It is not surprising that Joubert syndromes 2 and 14 (OMIM IDs 608091, 614424) grouped more closely with the central nervous system conditions cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome (OMIM ID 609528) rather than with Joubert syndromes 17, 18, 2, 3, 6, 7, 9 (OMIM IDs 614615, 614815, 608091, 608629, 610688, 611560, and 612285, respectively), in which systemic features play a more significant role. The pathway analysis using GeneMANIA module in Cytoscape software identified complex relationships among numerous GED loci. For example, two well-populated nodes involving COL11A1 and COL2A1 genes dominate the network for phenotype units ONH3 (glaucoma) and AL11 (myopia; Fig.  7 ) that belong to different ocular phenotype groups (optic nerve head for glaucoma and axial length for myopia). In this case, disease units that show significant phenotype-overlap are often clinically defined as a single entity (e.g., Stickler syndrome I and II caused by mutations in COL2A1 and COL11A1 genes, respectively). Also, diseases having noticeable overlap in phenotype units are caused by mutations in loci that fall into a single pathway (extracellular matrix organization; MYOC-LTBP2-PLOD1; Table 3, Supplementary Table S8 ). In a different scenario, phenotypes in the disease units are segregating into separate functional networks while being classified in the same phenotype group and developmental/ congenital condition as illustrated by the phenotype units DV12 (microphthalmia) and DV29 (hypertelorism; Fig. 7 , Table  3, Supplementary Table S8) . Interestingly, the top 10 phenotypic units in GEDs are variable in terms of their severity in vision impairment. For example, glaucoma (ONH3) is much more debilitating than ptosis (EL29), although ptosis is a bit more represented than glaucoma as a phenotypic unit in GEDs. In another instance, the number of GEDs having hypertelorism (DV29) as a phenotype is more than GEDs featuring microphthalmia (DV12; Table 3 ). These observations are intriguing as microphthalmia is a more severe pathophenotype in the ocular development than hypertelorism. The possible reason could be the arrangement of phenotype descriptions in OMIM where uncompromising, blinding disorders like microphthalmia (DV12) or glaucoma (ONH3) are also presented as phenotype units. On the contrary, hypertelorism (DV29) is a craniofacial abnormality, associated with many ocular and nonocular diseases and syndromes with more systemic than ocular features.
There could be criticisms in considering top 10 phenotype units for cluster analysis as single phenotype unit would mostly contain diseases featuring that specific phenotype unit along with the related ones to form a predictable cluster from the dataset. To counter this, we created clusters using the 0-1 matrix containing all ocular phenotypes (Fig. 8, Supplementary  Table S6 ). Similar analyses revealed a biological network from the largest cluster of all ocular phenotype dataset where ''acetyl CoA biosynthetic process from pyruvate'' and ''carbo- 
hydrate metabolism'' emerged as top biological process and top consolidated pathways-2013, respectively (Fig. 8) .
Abundance of neurologic or craniofacial systemic phenotypes in diseases having the top 10 ocular phenotypes (Fig. 5C) indicates toward the spatiotemporal proximity of the eye with central nervous system and cranium during development. However, consistent presence of skeletal, cardiovascular, and in some cases gastrointestinal phenotypes in diseases also having top 10 ocular phenotypes (Fig. 5C ) indicate a possible relationship of specific systemic phenotype with the ocular one. Nystagmus, strabismus, and ptosis showed a relatively greater number of associated systemic phenotypes (>500), while microphthalmia, glaucoma, and cataract showed a smaller number of associated systemic phenotypes (<400; Gene expression REACTOME Fig . 5C ). This result is indicative of the association of more systemic phenotypes with comparatively less severe blinding phenotypes, as vision impairment intensity is much less in nystagmus, strabismus, and ptosis when compared with glaucoma (ONH3), microphthalmia (DV12), or cataract (LE25). Interestingly, for glaucoma (ONH3) the number of skeletal phenotypes (69) is greater than neurologic phenotypes (50). This is intriguing as glaucoma is a neurodegenerative disease where more neurologic phenotypes are expected. When we looked specifically at the details of diseases having glaucoma as a phenotype, we detected seven such diseases having more than five skeletal features, ultimately giving rise to a greater number of skeletal features associated with glaucoma. Five out of these seven diseases are syndromes associated with multiple phenotypes with skeletal being the major one. The remaining two are diseases where skeletal features are composite with ocular phenotypes (Supplementary Table  S8 ). There is not much reported evidence to establish connection between skeletal phenotypes and glaucoma. Similarly, the presence of unusual craniofacial characteristics along the HRAS-RAF1-PTPN11 interaction recovers the known understanding of dysregulation of the RAS/mitogen activated protein kinase (MAPK) pathway. Moreover, the specific mutations in PTPN11 have been identified in LEOPARD (multiple lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonary stenosis, abnormal genitalia, retardation of growth, and sensorineural deafness) syndrome 11 that suggests that PTPN11 may have more general effects. Phenotype deconstruction thus can be very powerful for testing novel ideas that are mostly unexplored.
Other resources on human disorders are available in public databases such as DisGeNET and HPO. 5, 6 The primary source of information for both these databases and our study is OMIM. Our study primarily focused on analyzing the phenotype features for ocular diseases and linking the ocular and systemic annotations per disease, and identifying diseases that share individual ocular and systemic features. Our analysis intends to provide an insight of certain phenotypically similar disorders that share phenotype features such as Noonan syndrome (Supplementary Table S1 ). Studying phenotypic similarities is of great importance as it can reveal groups of genes in pathways or biochemical modules in which dysfunction could lead to similar phenotypic consequences. 12 Precise clinical observation defines the strength of phenotype clustering. One of the limitations of this study is the potential incompleteness of the phenotypic data available. The database OMIM describes the majority of human Mendelian syndromes in detail; however, computational analysis of the data contained in OMIM has so far been difficult due to the lack of a controlled vocabulary. A database containing phenotype annotation on all the organ systems and a more sturdy disease catalog would provide more powerful analyses. The association between the disease, gene, and phenotype could be established at the pathophysiological level when the gene expression analyses would be available for different components/tissues in the eye, lack of which prevented us from including them in these analyses. Therefore, we attempted to form categories and minimize feature deconstruction to reduce the inaccurate observations and bias in phenotypes reported in clinics for ocular diseases.
Phenotype deconvolution is an effective approach to explore and catalog relationships among human diseases 
through underlying features. This approach could be applicable to all diseases related to any organ. Furthermore, relationships among the phenotype, genotype, and feature spaces can introduce layout about biological mechanisms genetically linked to human disease.
